CA1108053A - Sustained release ophthalmic drug dosage - Google Patents

Sustained release ophthalmic drug dosage

Info

Publication number
CA1108053A
CA1108053A CA318,447A CA318447A CA1108053A CA 1108053 A CA1108053 A CA 1108053A CA 318447 A CA318447 A CA 318447A CA 1108053 A CA1108053 A CA 1108053A
Authority
CA
Canada
Prior art keywords
gel
ophthalmic
accordance
polymer
ophthalmic drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA318,447A
Other languages
English (en)
French (fr)
Inventor
Ronald D. Schoenwald
Robert E. Roehrs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Application granted granted Critical
Publication of CA1108053A publication Critical patent/CA1108053A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA318,447A 1978-01-25 1978-12-21 Sustained release ophthalmic drug dosage Expired CA1108053A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87207478A 1978-01-25 1978-01-25
US872,074 1978-01-25

Publications (1)

Publication Number Publication Date
CA1108053A true CA1108053A (en) 1981-09-01

Family

ID=25358780

Family Applications (1)

Application Number Title Priority Date Filing Date
CA318,447A Expired CA1108053A (en) 1978-01-25 1978-12-21 Sustained release ophthalmic drug dosage

Country Status (7)

Country Link
JP (2) JPS6059885B2 (xx)
CA (1) CA1108053A (xx)
CH (1) CH640737A5 (xx)
DE (1) DE2902863C2 (xx)
FR (1) FR2415459A1 (xx)
GB (1) GB2013084B (xx)
MX (1) MX6520E (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE6466T1 (de) 1979-10-26 1984-03-15 Smith And Nephew Associated Companies P.L.C. Autoklavierbare emulsionen.
GB2075837B (en) * 1980-05-14 1984-03-14 Hisamitsu Pharmaceutical Co Topical pharmaceutical gel containing anti-inflammatory analgesic agents
GB8500310D0 (en) * 1985-01-07 1985-02-13 Leo Pharm Prod Ltd Pharmaceutical preparation
US6255299B1 (en) 1985-01-07 2001-07-03 Leo Pharmaceutical Products Ltd. Opthalmic gel composition and method of treating eye infections
US5192535A (en) * 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
JP2873530B2 (ja) * 1991-12-13 1999-03-24 参天製薬株式会社 ニュートン型粘性を示すカルボキシビニルポリマー含有点眼液基剤
CN1049358C (zh) * 1993-01-01 2000-02-16 参天制药株式会社 含羧酸乙烯聚合物的滴眼剂及其制造方法
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
EP0748342B1 (en) 1994-03-04 2001-10-04 University of Washington Block and graft copolymers and methods relating thereto
US5683709A (en) * 1994-05-05 1997-11-04 Ciba Vision Corporation Poly(benzalkonium salt) as an anti-microbial agent for aqueous drug compositions
DE19614823A1 (de) * 1996-04-15 1997-10-16 Mann Gerhard Chem Pharm Fab Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge
DK1232173T3 (da) 1999-10-15 2003-09-29 Leo Pharma As Nye fusidinsyrederivater
DK1654002T4 (da) * 2003-08-07 2014-02-17 Allergan Inc Sammensætninger til fremføring af terapeutiske midler til øjnene
DE102010009475B4 (de) 2010-02-26 2011-11-24 F. Holzer Gmbh Verfahren zur Herstellung eines dosierbaren applikationsfertigen Präparates

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1012060A (en) * 1964-10-06 1977-06-14 Gilman N. Cyr Dimethyl sulfoxide gel preparations
DE2015300A1 (de) * 1969-04-01 1970-10-29 Syntex Corp., Panania;PM örtliche, entzündungshemmende Präparate und Verfahren zu ihrer Verwendung
DK135267A (xx) * 1971-02-25
DE2239206A1 (de) * 1971-08-12 1973-03-15 Hydrophilics Int Inc Copolymer
US3957740A (en) * 1972-04-24 1976-05-18 Hydrophilics International, Inc. Copolymers
FR2191941A1 (en) * 1972-07-10 1974-02-08 Serabonian Giacomo Gelatinising water-sol and aq liqs - by addn of carboxypolymer and alginic acid salt
DE2265164C3 (de) * 1972-10-18 1985-08-22 Vsesojuznyj naučno-issledovatel'skij i ispytatel'nyj institut medicinskoj techniki, Moskau/Moskva Verwendung von Acrylsäureamidcopolymeren zur Herstellung von Grundlagen für ophthalmologische Arzneiformen
AR206692A1 (es) * 1972-12-27 1976-08-13 Alza Corp Agente dispensador de liberacion sostenida de substancias activas
LU70487A1 (xx) * 1974-07-08 1976-05-31
US4003991A (en) * 1974-08-27 1977-01-18 National Patent Development Corporation Ophthalmic formulation
JPS5138412A (en) * 1974-09-24 1976-03-31 Nippon Kayaku Kk Kokoseizai no seiho
IL50250A (en) * 1975-08-27 1980-01-31 Hydrophilics Int Inc Sustained release compositions comprising slats of pharmaceutically acitve bases with polymers containing acid groups
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤

Also Published As

Publication number Publication date
JPS6059885B2 (ja) 1985-12-27
JPH0428244B2 (xx) 1992-05-13
JPS54110312A (en) 1979-08-29
FR2415459A1 (fr) 1979-08-24
DE2902863A1 (de) 1979-07-26
GB2013084B (en) 1982-07-28
FR2415459B1 (xx) 1983-03-18
MX6520E (es) 1985-06-27
CH640737A5 (de) 1984-01-31
GB2013084A (en) 1979-08-08
JPS62215518A (ja) 1987-09-22
DE2902863C2 (de) 1994-02-24

Similar Documents

Publication Publication Date Title
US4271143A (en) Sustained release ophthalmic drug dosage
US4407792A (en) Sustained release ophthalmic drug dosage
CA1108053A (en) Sustained release ophthalmic drug dosage
US5275820A (en) Stable suspension formulations of bioerodible polymer matrix microparticles incorporating drug loaded ion exchange resin particles
US5441732A (en) Reversible gelation emulsion compositions and methods of use
US5461081A (en) Topical ophthalmic pharmaceutical vehicles
US4115544A (en) Ocular system made of bioerodible esters having linear ether
WO1993017716A1 (en) Compositions for controlled delivery of pharmaceutical compounds
JPH08506588A (ja) アルカリ性眼科用懸濁液剤
WO1994010976A1 (en) Polyvinyl alcohol/borate ophthalmic drug delivery system
CA2147362C (en) Topical ophthalmic pharmaceutical vehicles
JP2536806B2 (ja) ゲル化多糖類と微粉砕された薬剤担体とを組み合わせた局部眼科用組成物
Dhyani et al. A new vision to eye: Novel ocular drug delivery system
WO1998011874A1 (en) Pharmaceutical composition forming a gel
JPH08510731A (ja) 治療使用のためのその場で生成するゲル
US5827835A (en) Thermally-gelling emulsions
JP3269770B2 (ja) 再分散性の優れたイオン性高分子配合水性懸濁点眼剤
EP0711147A1 (en) Suspensions for delivery of medicament
EP0424042A1 (en) Non-solid ophthalmic composition and process for preparing the said composition
WO1993018748A1 (en) Compositions comprising a drug delivery vehicle suspended in a nonaqueous fluorinated liquid
Manasa et al. FORMULATION AND EVALUATION OF MOXIFLOXACIN OCULAR MICROEMULSION GEL

Legal Events

Date Code Title Description
MKEX Expiry